Filter
799
Text search:
prévention
des
maladies
Featured
Recommendations
94
New Publications
147
Language
Document type
No document type
332
Guidelines
173
Studies & Reports
98
Strategic & Response Plan
63
Manuals
56
Fact sheets
32
Training Material
25
Brochures
5
Situation Updates
5
Infographics
4
Online Courses
4
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
Senegal
65
Congo, Democratic Republic of
48
Global
43
Burkina Faso
37
Africa
34
West and Central Africa
25
Benin
21
Mali
18
Haiti
18
Guinea
17
Côte d’Ivoire / Ivory Coast
17
Cameroon
17
Togo
10
Rwanda
10
East and Southern Africa
10
Latin America and the Carribbean
10
Niger
8
Central African Republic
8
Middle East and North Africa
8
France
8
Madagascar
7
Chad
6
India
5
Congo-Brazzaville
5
Burundi
4
South–East Asia Region
4
Canada
4
Sierra Leone
3
Liberia
3
Ethiopia
3
Bangladesh
3
Luxembourg
3
Djibouti
3
North America
3
Belgium
3
Nigeria
2
Ghana
2
Uganda
2
Zimbabwe
2
South Sudan
2
Syria
2
Kenya
2
Angola
2
Western and Central Europe
2
Asia
2
Eastern Europe
2
Russia
2
Guinea-Bissau
1
Morocco
1
Somalia
1
Nepal
1
Germany
1
Zambia
1
Turkey
1
Tanzania
1
China
1
South Africa
1
Malawi
1
Mozambique
1
Sudan
1
Argentina
1
Namibia
1
Brazil
1
Ukraine
1
Gabon
1
Algeria
1
Authors & Publishers
Publication Years
Category
Countries
242
Public Health
161
Clinical Guidelines
129
Women & Child Health
44
Key Resources
40
Capacity Building
18
Pharmacy & Technologies
18
Toolboxes
COVID-19
103
Malaria
49
Rapid Response
47
Ebola & Marburg
43
HIV
34
TB
33
Mental Health
32
NTDs
27
2.0 Rapid Response
26
Cholera
22
Caregiver
19
AMR
18
Zika
16
NCDs
15
Disability
14
Planetary Health
10
Polio
8
Refugee
8
Pharmacy
8
Natural Hazards
6
Global Health Education
5
Health Financing Toolbox
2
Conflict
1
Specific Hazards
1
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments
...
Cystic fibrosis (CF) was earlier thought to be a disease prevalent in the West among Caucasians. However, quite a number of recent studies have uncovered CF cases outside of this region, and reported hundreds of unique and novel variant forms of CFTR. Here, we discuss the evidence of CF in parts of
...
The “ActiveAge Handbook” is an outcome of the “ActiveAge Project, which was carried out from January 2013 until June 2014 in the frame of “2012 Preparatory Actions in the Field of Sport” of the European Commission Directory General Education and Cul-
ture (DG EAC) in cooperation with 13 E
...
The ninth WHO report on the global tobacco epidemic tracks the progress made by countries in tobacco control since 2008 and, marks 15 years since the introduction of the MPOWER technical package which is designed to help countries implement the demand-reduction measures of the WHO Framework Conventi
...
This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 ("the road map") aims to support a range of stakeholders - including countries in which neglected tropical diseases (NTDs) are endemic, international organi
...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac
...
Risk assessment and priority interventions
The document provides detailed clinical guidelines for the therapy of Type 1 Diabetes as developed by the German Diabetes Association (DDG). It focuses on individualized insulin therapy, structured patient training, and monitoring of blood glucose levels. The guidelines emphasize preventing complica
...
Building true health security in a global age. Findings and recommendations of the Global Council. In landmark findings based on two years of research and convenings around the world, the new report shows that high levels of inequality are linked to outbreaks becoming pandemics and that inequality i
...
Operational Guidance. This operational guidance provides a structured approach to support countries in sustaining priority services for HIV, viral hepatitis and sexually transmitted infections in the context of reduced external funding. The guidance is intended for national governments, public healt
...
Cholera epidemics continue to be a major public health problem in many countries around the
world. When epidemics strike, they can spread rapidly. The disease can also evolve quickly;
patients with severe disease can die of dehydration hours after showing the first symptoms of
cholera.
Le flyer „MMV Strategy“ présente la stratégie de la Medicines for Malaria Venture (MMV) pour lutter contre le paludisme. Il met en avant les objectifs clés de l'organisation, qui se concentre sur la recherche et le développement de nouveaux médicaments antipaludiques. Le document décrit le
...
This technical briefing paper details the construction and setup of medical isolation facilities in support of infectious disease outbreak responses.
